82 related articles for article (PubMed ID: 17975794)
21. Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs.
Ribas J; Boix J
Exp Cell Res; 2004 Apr; 295(1):9-24. PubMed ID: 15051486
[TBL] [Abstract][Full Text] [Related]
22. The cyclin-dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker.
Krucher NA; Meijer L; Roberts MH
Cell Mol Neurobiol; 1997 Oct; 17(5):495-507. PubMed ID: 9353591
[TBL] [Abstract][Full Text] [Related]
23. Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs.
Ribas J; Gomez-Arbones X; Boix J
Eur J Pharmacol; 2005 Nov; 524(1-3):49-52. PubMed ID: 16243312
[TBL] [Abstract][Full Text] [Related]
24. Early inhibition of DNA synthesis in the developing rat cerebral cortex by the purine analogues olomoucine and roscovitine.
Yakisich JS; Sidén A; Idoyaga Vargas V; Eneroth P; Cruz M
Biochem Biophys Res Commun; 1998 Feb; 243(3):674-7. PubMed ID: 9500988
[TBL] [Abstract][Full Text] [Related]
25. Roscovitine inhibits the proliferative activity of immortal and neoplastic human breast epithelial cells.
Mgbonyebi OP; Russo J; Russo IH
Anticancer Res; 1998; 18(2A):751-5. PubMed ID: 9615715
[TBL] [Abstract][Full Text] [Related]
26. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine.
Schulze-Gahmen U; Brandsen J; Jones HD; Morgan DO; Meijer L; Vesely J; Kim SH
Proteins; 1995 Aug; 22(4):378-91. PubMed ID: 7479711
[TBL] [Abstract][Full Text] [Related]
27. Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia.
Sankrithi N; Eskin A
J Neurochem; 1999 Feb; 72(2):605-13. PubMed ID: 9930732
[TBL] [Abstract][Full Text] [Related]
28. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
Zhang M; Li J; Chakrabarty P; Bu B; Vincent I
Am J Pathol; 2004 Sep; 165(3):843-53. PubMed ID: 15331409
[TBL] [Abstract][Full Text] [Related]
29. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
Wesierska-Gadek J; Gueorguieva M; Horky M
Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
[TBL] [Abstract][Full Text] [Related]
30. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L
Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745
[TBL] [Abstract][Full Text] [Related]
31. Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells.
Nuckolls FJ; Khan AS; Butler R; Katula KS
Biochem Biophys Res Commun; 1998 Mar; 244(1):280-4. PubMed ID: 9514874
[TBL] [Abstract][Full Text] [Related]
32. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
Moreau JL; Marques F; Barakat A; Schatt P; Lozano JC; Peaucellier G; Picard A; Genevière AM
Dev Biol; 1998 Aug; 200(2):182-97. PubMed ID: 9705226
[TBL] [Abstract][Full Text] [Related]
33. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein.
Ratner N; Bloom GS; Brady ST
J Neurosci; 1998 Oct; 18(19):7717-26. PubMed ID: 9742142
[TBL] [Abstract][Full Text] [Related]
34. [Effects of cyclin dependent protein kinase inhibitor olomoucine on the neuronal apoptosis after status epilepticus: experiment with rats].
Du XP; Sun MZ; Yu ZY; Chen HX; Tian DS; Xie MJ; Wang W
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2025-9. PubMed ID: 17925171
[TBL] [Abstract][Full Text] [Related]
35. CDK inhibitors suppress apoptosis induced by chemicals and by excessive expression of a cell death gene, reaper, in Drosophila cells.
Nagano M; Ui-Tei K; Suzuki H; Piao Z; Miyata Y
Apoptosis; 2000 Dec; 5(6):543-50. PubMed ID: 11303913
[TBL] [Abstract][Full Text] [Related]
36. Cyclin-dependent kinase (CDK) inhibitor olomoucine enhances gamma-irradiation-induced apoptosis and cell cycle arrest in Raji cells.
Boutis A; Papazisis K; Pistevou-Gompaki K; Lambropoulos A; Sofroniadis I; Papageorgiou A; Destouni E; Kortsaris A
Anticancer Res; 2006; 26(5A):3493-8. PubMed ID: 17094472
[TBL] [Abstract][Full Text] [Related]
37. Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons.
Appert-Collin A; Hugel B; Levy R; Niederhoffer N; Coupin G; Lombard Y; André P; Poindron P; Gies JP
Life Sci; 2006 Jun; 79(5):484-90. PubMed ID: 16530228
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
Wesierska-Gadek J; Kramer MP; Maurer M
Food Chem Toxicol; 2008 Apr; 46(4):1327-33. PubMed ID: 17933449
[TBL] [Abstract][Full Text] [Related]
39. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
Havlícek L; Hanus J; Veselý J; Leclerc S; Meijer L; Shaw G; Strnad M
J Med Chem; 1997 Feb; 40(4):408-12. PubMed ID: 9046330
[TBL] [Abstract][Full Text] [Related]
40. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
Matsuoka M; Tani K; Asano S
Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
